Rodin Therapeutics is discovering and developing first in class therapeutics for neurological disorders.
Location: United States, Massachusetts, Cambridge
Total raised: $57.2M
Investors 4
Date | Name | Website |
- | ShangPharm... | spiivc.com |
- | Third Poin... | thirdpoint... |
- | Atlas Vent... | atlasventu... |
- | GV | gv.com |
Funding Rounds 3
Date | Series | Amount | Investors |
18.09.2017 | - | $27M | - |
06.01.2016 | - | $17.3M | - |
29.05.2014 | Series A | $12.9M | - |
Mentions in press and media 13
Date | Title | Description | Source |
23.04.2024 | Seamless Therapeutics Announces New CEO and Board Chairman t... | DRESDEN, Germany & LEXINGTON, Mass.--(BUSINESS WIRE)-- Seamless Therapeutics today announced the... | forbion.co... |
18.04.2019 | Failure of once-promising Alzheimer’s drug reinforces doubts... | But last month, Biogen and its partner, Japan’s Eisai, shocked the world by halting the Phase III st... | medcitynew... |
16.04.2019 | The trouble with mice as behavioral models for Alzheimer’s a... | There’s been a lot of talk about overinvestment in interventions aimed at amyloid in the weeks since... | statnews.c... |
20.09.2017 | Term Sheet — Wednesday, September 20 | THE ROBOTS ARE COMING Good morning, Term Sheet readers. Paid Content Securing the enterprise without... | fortune.co... |
18.09.2017 | Rodin Therapeutics Raises $27M in Financing | Rodin Therapeutics, a Cambridge, MA-based biotechnology company discovering and developing novel the... | finsmes.co... |
18.09.2017 | Rodin Therapeutics Grabs $27M | CAMBRIDGE, MA, Rodin Therapeutics completes $27 million financing round. >> Click here for ... | vcnewsdail... |
06.01.2016 | Rodin Therapeutics Raises $17.3M in Funding | Rodin Therapeutics, a Cambridge, MA-based biotechnology company applying insights from epigenetics t... | finsmes.co... |
06.10.2015 | Rodin Therapeutics Appoints Adam J. Rosenberg as CEO | The Board of Directors of Rodin Therapeutics, a Cambridge, MA-based biotechnology company applying i... | finsmes.co... |
19.06.2014 | J&J early stage collaborations span 3D printing for orth... | Brown fat as metabolic disorder treatment: Unlike normal fat cells, brown fat cells convert energy f... | medcitynew... |
29.05.2014 | Rodin Secures $12.9M Series A Financing | CAMBRIDGE, MA, Biotechnology company applying insights of epigenetics to novel therapeutics for ne... | vcnewsdail... |
Show more